Aurobindo Pharma to buyback FCCBs

The Hyderabad based Aurobindo Pharma said the company would buy back a portion of  their outstanding Foreign Currency Convertable Bonds (FCCBs).

Aurobindo has an outstanding $200 million FCCBs, which will mature in May, 2011.

"Such purchase shall be effected subject to the availability of sufficient funds with the Company and subject to prevailing market conditions. The Company has appointed Barclays Capital for the same," the company informed the stock exchanges.